Good results, open at depth, drilling on-going, more results to come. Plus cashed up, low cap, low shares on issue. Makes for a good story at these prices.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025